These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7837224)

  • 1. New antianginal nitro esters with reduced hypotensive activity. Synthesis and pharmacological evaluation of 3-[(nitrooxy)alkyl]-2H-1,3-benzoxazin-4(3H)-ones.
    Benedini F; Bertolini G; Cereda R; Donà G; Gromo G; Levi S; Mizrahi J; Sala A
    J Med Chem; 1995 Jan; 38(1):130-6. PubMed ID: 7837224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil.
    Ueno A; Bergamaschi M; Gromo G; Nonaka K; Mizrahi J
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S13-20. PubMed ID: 8839221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiohaemodynamic effects of long-term intravenous administration of N-(2-hydroxyethyl)nicotinamide nitrate (SG-75), a potent coronary vasodilator: comparison with glyceryl trinitrate.
    Sakai K; Shiraki Y; Yamazaki T; Akima M; Nabata H; Ohba Y
    Clin Exp Pharmacol Physiol; 1981; 8(6):557-65. PubMed ID: 6460572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of the nitrate ester ITF 296 against methacholine-induced myocardial ischemia in the anesthetized rat.
    Cereda R; Bergamaschi M; Agozzino S; Bravi F; Gromo G; Mascheroni G; Mizrahi J
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S37-43. PubMed ID: 8839225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional and cardiac haemodynamic responses to glyceryl trinitrate, acetylcholine, bradykinin and endothelin-1 in conscious rats: effects of NG-nitro-L-arginine methyl ester.
    Gardiner SM; Compton AM; Kemp PA; Bennett T
    Br J Pharmacol; 1990 Nov; 101(3):632-9. PubMed ID: 2127552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of JTV-506, a novel vasodilator, on experimental angina model in rats.
    Hirata Y; Miyai H; Mabuchi Y; Aisaka K
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):322-6. PubMed ID: 9475276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotensive effects and biotransformation of nicorandil, a new antianginal agent, administered to rats by different routes: comparison with nitroglycerin and isosorbide dinitrate.
    Sakai K; Akima M; Hinohara Y; Obatake N
    J Pharm Pharmacol; 1984 Mar; 36(3):175-81. PubMed ID: 6144752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discovery of a new organic nitrate: an overview.
    Benedini F; Bertolini G; Gromo G; Mizrahi J; Sala A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S1-5. PubMed ID: 8839219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the acute hemodynamic and coronary vasodilating effects between nicorandil and glyceryl trinitrate.
    Chibana T; Nagamine F; Sunagawa R; Oshiro K; Nakada Y; Shimabukuro M; Shinzato T; Murakami K; Mimura G; Sakanashi M
    Arzneimittelforschung; 1991 Jun; 41(6):591-4. PubMed ID: 1834065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology and therapeutic effects of nicorandil.
    Kinoshita M; Sakai K
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1075-88. PubMed ID: 2150592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
    Frampton J; Buckley MM; Fitton A
    Drugs; 1992 Oct; 44(4):625-55. PubMed ID: 1281076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of antianginal drugs on Lypressin induced T-wave enhancement in the electrocardiogram of the rat].
    Leitold M; Hader S
    Arzneimittelforschung; 1986 Oct; 36(10):1454-7. PubMed ID: 2949754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of N-(2-hydroxyethyl)nicotinamide nitrate (SG-75) on methacholine-induced ECG changes in intact anesthetized rats.
    Aono J; Akima M; Sakai K
    Jpn J Pharmacol; 1981 Oct; 31(5):823-30. PubMed ID: 6458723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term increases in coronary arterial conductance during five day infusion of low dose nicorandil.
    Bassenge E; Fink B; Sommer O; Huckstorf C
    Cardiovasc Res; 1994 Jun; 28(6):912-6. PubMed ID: 7923298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infarct size-reducing effect of nicorandil is mediated by the KATP channel but not by its nitrate-like properties in dogs.
    Mizumura T; Nithipatikom K; Gross GJ
    Cardiovasc Res; 1996 Aug; 32(2):274-85. PubMed ID: 8796114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of nicorandil-induced relaxation, elevations of cyclic guanosine monophosphate and stimulation of guanylate cyclase with organic nitrate esters.
    Greenberg SS; Cantor E; Ho E; Walega M
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1061-71. PubMed ID: 1679847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nicorandil on coronary circulation in patients with ischemic heart disease: comparison with nitroglycerin.
    Aizawa T; Ogasawara K; Kato K
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S123-9. PubMed ID: 2447419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy.
    Krumenacker M; Roland E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S93-102. PubMed ID: 1282184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary microvascular response to intracoronary administration of nicorandil.
    Hongo M; Takenaka H; Uchikawa S; Nakatsuka T; Watanabe N; Sekiguchi M
    Am J Cardiol; 1995 Feb; 75(4):246-50. PubMed ID: 7832132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypotensive, antianginal action and pharmacokinetics of glyceryl-1-nitrate in rats and dogs].
    Leitold M; Laufen H; Yeates RA
    Arzneimittelforschung; 1986 Nov; 36(11):1577-82. PubMed ID: 3101710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.